UCBJY:OTCMKTS
UCB Unsponsored Belgium ADR
114,46 USD
arrow_downward
−0,87%(−1,01) 1 D
16. okt., 16:00:00 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for UCBJY …
Åpne
114,95 USD
Høy
115,28 USD
Lav
114,23 USD
Markedsverdi
39,39 mrd.
Snittvolum
53,31k
Volum
70,57k
52 u høy
168,76 USD
52 u lav
110,55 USD
Beta
0,57
Utestående aksjer
389,01 mill.
Antall ansatte
9k
Åpne
114,95 USD
Høy
115,28 USD
Lav
114,23 USD
Markedsverdi
39,39 mrd.
Snittvolum
53,31k
Volum
70,57k
52 u høy
168,76 USD
52 u lav
110,55 USD
Beta
0,57
Utestående aksjer
389,01 mill.
Antall ansatte
9k
Nyhetssaker
Fra nettkilder og nyhetspartnere
ad-hoc-news.de
·
for 20 timer siden
UCB revises Bimzelx potential above EUR 7 billion: UCB stock sits 30.28 percent below its high
ad-hoc-news.de
·
for 1 døgn siden
UCB dedicates Georgia campus as UCB stock sits 29.15 percent below its high
Profil
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology.
Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
Om UCB Unsponsored Belgium ADR
Administrerende direktørJean-Christophe Tellier
Ansatte9k
Grunnlagt18. jan. 1928
Hovedkontor-
Sektor-
Nettsteducb.com